N Honhold|D A Smith - JoVE Visualize

Showing results (371-380 of 408) with videos related to

Pageof 41

Sort By:

Drug and Alcohol Dependence|November 1, 1995

Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndromeD H Malin, J R Lake, D A Smith, et al.

Peerj|November 29, 2023

Genomic analyses indicate resilience of a commercially and culturally important marine gastropod snail to climate changeMatt J Nimbs, Curtis Champion, Simon E Lobos, et al.

Journal of Medicinal Chemistry|August 19, 1994

Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonistsP G Dunbar, G J Durant, T Rho, et al.

Chemical Research in Toxicology|December 21, 2004

Time course toxicogenomic profiles in CD-1 mice after nontoxic and nonlethal hepatotoxic paracetamol administrationD P Williams, C Garcia-Allan, G Hanton, et al.

Thrombosis and Haemostasis|May 24, 2000

Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effectG Dangas, D A Smith, A H Unger, et al.

Science (New York, N.Y.)|February 1, 1980

Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes?R B Mailman, R M Ferris, F L Tang, et al.

Lupus|February 1, 1993

Expression and relationships of seven public idiotypes of DNA-binding autoantibodies on monoclonal antibodies and serum immunoglobulinsN A Staines, C T Ravirajan, A Morgan, et al.

The American Journal of Cardiology|September 25, 1999

Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatinG Dangas, D A Smith, J J Badimon, et al.

Peptides|January 1, 1996

Enhanced antiopiate activity and enzyme resistance in a peptidomimetic of FMRFamide containing E-2,3-methanomethionine and E-2,3-methanophenylalanineD H Malin, J R Lake, L S McDermitt, et al.

Brain : a Journal of Neurology|March 5, 2003

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosisM Jeyakumar, R Thomas, E Elliot-Smith, et al.

Pageof 41

Showing results (371-380 of 408) with videos related to

Sort By:

Pageof 41

Drug and Alcohol Dependence|November 1, 1995

Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndromeD H Malin, J R Lake, D A Smith, et al.

Peerj|November 29, 2023

Genomic analyses indicate resilience of a commercially and culturally important marine gastropod snail to climate changeMatt J Nimbs, Curtis Champion, Simon E Lobos, et al.

Journal of Medicinal Chemistry|August 19, 1994

Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonistsP G Dunbar, G J Durant, T Rho, et al.

Chemical Research in Toxicology|December 21, 2004

Time course toxicogenomic profiles in CD-1 mice after nontoxic and nonlethal hepatotoxic paracetamol administrationD P Williams, C Garcia-Allan, G Hanton, et al.

Thrombosis and Haemostasis|May 24, 2000

Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effectG Dangas, D A Smith, A H Unger, et al.

Science (New York, N.Y.)|February 1, 1980

Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes?R B Mailman, R M Ferris, F L Tang, et al.

Lupus|February 1, 1993

Expression and relationships of seven public idiotypes of DNA-binding autoantibodies on monoclonal antibodies and serum immunoglobulinsN A Staines, C T Ravirajan, A Morgan, et al.

The American Journal of Cardiology|September 25, 1999

Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatinG Dangas, D A Smith, J J Badimon, et al.

Peptides|January 1, 1996

Enhanced antiopiate activity and enzyme resistance in a peptidomimetic of FMRFamide containing E-2,3-methanomethionine and E-2,3-methanophenylalanineD H Malin, J R Lake, L S McDermitt, et al.

Brain : a Journal of Neurology|March 5, 2003

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosisM Jeyakumar, R Thomas, E Elliot-Smith, et al.

Pageof 41